(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.49%) $78.49
(0.70%) $2.16
(0.60%) $2 322.50
(1.85%) $27.18
(-0.35%) $961.95
(-0.02%) $0.929
(-0.19%) $10.85
(-0.04%) $0.797
(0.00%) $91.45
-0.61% $ 9.80
Live Chart Being Loaded With Signals
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions...
Stats | |
---|---|
Volumen de hoy | 5 053.00 |
Volumen promedio | 2 768.00 |
Capitalización de mercado | 46.40M |
EPS | $0 ( 2024-03-13 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-10 |
Last Dividend | $0.0300 ( 2018-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 70.00 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Michel Robert J | Buy | 750 | Daxor Common Stock |
2024-03-04 | Feuer Edward | Buy | 1 000 | Daxor Common Stock |
2023-12-06 | Michel Robert J | Buy | 120 | Daxor Common Stock |
2023-12-01 | Michel Robert J | Buy | 180 | Daxor Common Stock |
2023-12-01 | Feldschuh Michael Richard | Buy | 800 | Daxor Common Stock |
INSIDER POWER |
---|
56.67 |
Last 97 transactions |
Buy: 668 992 | Sell: 434 444 |
Daxor Corp Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Daxor Corp Finanzas
Annual | 2023 |
Ingresos: | $34.59M |
Beneficio Bruto: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2023 |
Ingresos: | $34.59M |
Beneficio Bruto: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2022 |
Ingresos: | $6.31M |
Beneficio Bruto: | $5.22M (82.77 %) |
EPS: | $1.270 |
FY | 2021 |
Ingresos: | $5.82M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $1.170 |
Financial Reports:
No articles found.
Daxor Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 1997-04-28 |
Last Dividend | $0.0300 | 2018-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2018-01-12 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.11 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.17 | -- |
Div. Sustainability Score | 2.66 | |
Div.Growth Potential Score | 0.487 | |
Div. Directional Score | 1.571 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NEN | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
WTV | Ex Dividend Junior | 2023-06-26 | Quarterly | 0 | 0.00% | |
CET | Ex Dividend Knight | 2023-06-09 | Semi-Annually | 0 | 0.00% | |
FRD | Ex Dividend Knight | 2023-10-19 | Quarterly | 0 | 0.00% | |
MMCA | Ex Dividend Junior | 2023-09-01 | Bi-Monthly | 0 | 0.00% | |
SVOL | Ex Dividend Junior | 2023-08-28 | Monthly | 0 | 0.00% | |
BITO | Ex Dividend Knight | 2023-09-01 | Bi-Monthly | 0 | 0.00% | |
ESP | Ex Dividend Knight | 2023-06-22 | Semi-Annually | 0 | 0.00% | |
RIET | Ex Dividend Junior | 2023-09-12 | Monthly | 0 | 0.00% | |
AE | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0121 | 1.500 | 9.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0121 | 1.200 | 9.60 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0131 | 1.500 | -0.966 | -1.449 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.251 | 0.800 | -3.74 | -3.00 | [1 - 3] |
quickRatioTTM | 0.138 | 0.800 | -3.90 | -3.12 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.0217 | -1.500 | 9.64 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6.56 | 1.000 | -3.54 | -3.54 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.856 | -1.712 | [0 - 20] |
debtEquityRatioTTM | 0.0222 | -1.500 | 9.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.987 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.00928 | 1.000 | -2.19 | -2.19 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -10.89 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.994 | 0.800 | 6.70 | 5.36 | [0.5 - 2] |
Total Score | 2.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 111.89 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0131 | 2.50 | -0.621 | -1.449 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.712 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.286 | 1.500 | 4.76 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.237 | 1.000 | -8.43 | 0 | [0.1 - 0.5] |
Total Score | 0.487 |
Daxor Corp
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico